We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+5.54%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.54%
AUM
$106B
AUM Growth
+$15.3B
Cap. Flow
+$2.93B
Cap. Flow %
2.78%
Top 10 Hldgs %
16.94%
Holding
4,486
New
287
Increased
1,717
Reduced
1,772
Closed
419

Top Buys

Rank Stock Value
1
GDX icon
VanEck Gold Miners ETF
GDX
+$708M
2
USB icon
US Bancorp
USB
+$349M
3
JPM icon
JPMorgan Chase
JPM
+$255M
4
MON
Monsanto Co
MON
+$210M
5
MPLX icon
MPLX
MPLX
+$205M

Sector Composition

Rank Sector Weight
1 Miscellaneous 27.1%
2 Financials 11.73%
3 Technology 11.03%
4 Healthcare 9.79%
5 Consumer Discretionary 7.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYTR
3826
DELISTED
CytRx Corp
CYTR
$42K ﹤0.01%
11,993
+6,485
+118% +$29.7K
DNN icon
3827
Denison Mines
DNN
$2.59B
$41K ﹤0.01%
88,123
-176,736
-67% -$91.4K
FBIO icon
3828
Fortress Biotech
FBIO
$83M
$41K ﹤0.01%
918
-573
-38% -$24.4K
BSPM
3829
DELISTED
Biostar Pharmaceuticals, Inc.
BSPM
$41K ﹤0.01%
11,023
-18,093
-62% -$66K
PLUR icon
3830
Pluri
PLUR
$14.4M
$40K ﹤0.01%
313
IPI icon
3831
Intrepid Potash
IPI
$520M
$39K ﹤0.01%
3,419
-24,674
-88% -$323K
MCHX icon
3832
Marchex
MCHX
$54.5M
$37K ﹤0.01%
13,322
-12,519
-48% -$37.1K
WPRT
3833
Westport Fuel Systems
WPRT
$37.4M
$36K ﹤0.01%
2,213
-2,185
-50% -$31.9K
WG
3834
DELISTED
Willbros Group
WG
$35K ﹤0.01%
18,668
-11,453
-38% -$23.5K
APVO icon
3835
Aptevo Therapeutics
APVO
$3.1M
0
NAGE
3836
Niagen Bioscience
NAGE
$237M
$34K ﹤0.01%
11,382
-740
-6% -$2.72K
GLF
3837
DELISTED
GulfMark Offshore, Inc. Common Stock
GLF
$32K ﹤0.01%
18,952
-95,032
-83% -$248K
LYG icon
3838
Lloyds Banking Group
LYG
$84.9B
$31K ﹤0.01%
+10,900
New +$32.4K
BDSI
3839
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$31K ﹤0.01%
11,649
-133,167
-92% -$338K
RXII
3840
DELISTED
GALENA BIOPHARMA INC COM
RXII
$30K ﹤0.01%
88,987
-48,689
-35% -$16.4K
SOL
3841
DELISTED
Emeren Group
SOL
$29K ﹤0.01%
5,740
-5,920
-51% -$34.3K
MEMP
3842
DELISTED
Memorial Production Partners LP Common Units
MEMP
$29K ﹤0.01%
16,500
-1,070,338
-98% -$1.89M
GSS
3843
DELISTED
Golden Star Resources Ltd.
GSS
$28K ﹤0.01%
+6,740
New +$26.4K
IIP
3844
DELISTED
INTERNAP NETWORK SERVICES CORPORATION
IIP
$28K ﹤0.01%
17,086
-211,677
-93% -$347K
NWBO
3845
CALL
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$27K ﹤0.01%
50,000
VHI icon
3846
Valhi
VHI
$500M
$25K ﹤0.01%
905
-397
-30% -$9.98K
MHGC
3847
DELISTED
Morgans Hotel Group Co.
MHGC
$25K ﹤0.01%
12,339
-91,812
-88% -$204K
CVRS
3848
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$23K ﹤0.01%
20,813
-9,534
-31% -$12.8K
BINI
3849
DELISTED
Bollinger Innovations
BINI
0
AMPE
3850
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$18K ﹤0.01%
82
-10
-11% -$2.8K

Similar funds

Credit Suisse's Q3 2016 Portfolio in Review

As of Q3 2016, Credit Suisse held 4,486 positions worth $106B, up 17% from $90.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Credit Suisse's Q3 2016 filing shows 287 new, 1,717 increased, 1,772 reduced and 419 closed positions. Its largest new stake was iShares Core S&P Small-Cap ETF: 2,400,274 shares worth $149M. The largest sale was EMC CORPORATION, an estimated $410M.

By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 22% a quarter earlier, followed by Financials and Technology.

  • Credit Suisse's largest Q3 2016 buy was iShares Core S&P Small-Cap ETF: 2,400,274 shares worth $149M.
  • Credit Suisse added most to VanEck Gold Miners ETF in Q3 2016, an estimated $708M increase.
  • Credit Suisse's biggest Q3 2016 reduction was Williams Companies, cutting an estimated $350M.
  • Credit Suisse fully exited EMC CORPORATION in Q3 2016, selling an estimated $410M.
  • Credit Suisse's ten largest holdings make up 17% of its $106B portfolio in Q3 2016.
  • Credit Suisse opened 287 new positions and closed 419 in Q3 2016.
  • Credit Suisse's portfolio value rose 17% quarter-over-quarter to $106B.

Based on Credit Suisse's 13F filing for Q3 2016, filed 15 Nov 2016.